Clinical Trial Update: Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating cardiometabolic changes and energy balance recovery after stopping semaglutide in individuals with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Obesity (Disorder), Weight Change | Phase 3 | Status: RECRUITING